Pharsight

Drug patents revoked in 2020

Drug patents revoked in 2020 at the European Patent Office (EPO)

Patent Number Patent Title Company Revoked Date Oppositions
EP1997473B1 Use Of A Multi-Carbosite, Multi-Group Coupling Agent For Protecting The Colour Of Artificially Dyed Keratin Fibres With Respect To Washing; Dyeing Processes LOREAL SA Dec, 2020
(Expiration: Apr, 2028)
HENKEL
EP2044947B1 Compositions And Methods OXFORD UNIVERSITY INNOVATION LTD Dec, 2020
(Expiration: Dec, 2027)
IMUTEX
EP2349332B1 Methods And Compositions For Regulating Iron Homeostasis By Modulation Bmp-6 GENERAL HOSPITAL CORP Dec, 2020
(Expiration: Nov, 2029)
MATHYS & SQUIRE
EP2355902B1 Nutritional Compositions With Coated Lipid Globules NUTRICIA NV Dec, 2020
(Expiration: Dec, 2029)
ABBOTT LABORATORIES
CARGILL
EP1441702B1 Method For Treating Primary Insomnia NEURIM PHARMACEUTICALS 1991 LTD Dec, 2020
(Expiration: Aug, 2022)
ASPIRE PHARMA
GENERICS UK
TEVA PHARMACEUTICAL INDUSTRIES
EP2734185B1 Dyeing Process Using A Natural Dye On Keratin Fibres That Have Undergone Permanent Reshaping LOREAL SA Dec, 2020
(Expiration: Jul, 2032)
KAO GERMANY
EP3060195B1 Cosmetic Composition Based On Hyaluronic Acid, Method Of Preparation And Use Thereof CONTIPRO AS Dec, 2020
(Expiration: Oct, 2034)
STELLENBOSCH NANOFIBER
EP2198833B1 Method Of Coloring Or Lightening Of Human Keratinic Fibers With An Anhydrous Composition And An Inorganic Base And Kit LOREAL SA Dec, 2020
(Expiration: Dec, 2029)
HENKEL
EP2787965B1 Composition Based On Red Henna Powder And Oil(S), And Hair Dyeing Process Using This Composition LOREAL SA Dec, 2020
(Expiration: Dec, 2032)
COTY
HENKEL
EP2792715B1 Semi-Synthetic Or Synthetic Vaselines AIGLON Dec, 2020
(Expiration: Mar, 2034)
SASOL WAX
EP2187965B1 Psma Binding Ligand-Linker Conjugates And Methods For Using PURDUE RESEARCH FOUNDATION Dec, 2020
(Expiration: Aug, 2028)
BOULT WADE TENNANT
ORANO MED
EP1294379B1 A New Use For Deferiprone APOTEX INC Dec, 2020
(Expiration: Jun, 2021)
LIPOMED
EP2214642B1 Topical Composition NOVARTIS CONSUMER HEALTH SA Dec, 2020
(Expiration: Oct, 2028)
KERN PHARMA
PRFER & PARTNER MBB
EP2345400B1 Lightening Composition Having Reduced Hair Damage HENKEL AG AND CO KGAA Dec, 2020
(Expiration: Nov, 2030)
KAO GERMANY
EP3050556B1 Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate TEVA PHARMACEUTICAL INDUSTRIES LTD Nov, 2020
(Expiration: Sep, 2035)
GENERICS UK TRADING MYLAN
WITTKOPP
EP3031920B1 Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression IONIS PHARMACEUTICALS INC Nov, 2020
(Expiration: Jul, 2031)
STRAWMAN
EP2687213B1 Solid Forms Comprising (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione, Compositions Thereof, And Uses Thereof CELGENE CORP Nov, 2020
(Expiration: Mar, 2028)
GENERICS UK
EP3340990B1 Pharmaceutical Combinations Comprising (A) The Cyclin Dependent Kinase 4/6 (Cdk4/6) Inhibitor Lee011 (=Ribociclib), And (B) The Epidermal Growth Factor Receptor (Egfr) Inhibitor Erlotinib, For The Treatment Or Prevention Of Cancer NOVARTIS AG Nov, 2020
(Expiration: Aug, 2036)
GENERICS UK
EP3456374B1 Implant Syringe GAPLAST GMBH Nov, 2020
(Expiration: Aug, 2038)
AMW
EP3068396B1 Rapidly Disintegrating Formulations And Methods Of Use IMPAX LABORATORIES LLC Oct, 2020
(Expiration: Nov, 2034)
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
EP2288717B1 Monoclonal Antibodies To Basic Fibroblast Growth Factor GALAXY BIOTECH LLC Oct, 2020
(Expiration: May, 2029)
STRAWMAN
EP3312196B1 Antibodies Against Cd38 For Treatment Of Multiple Myeloma GENMAB AS Oct, 2020
(Expiration: Mar, 2026)
SECERNA
EP2200588B1 Compositions Comprising Lipophilic Active Compounds And Method For Their Preparation SOLUBEST LTD Oct, 2020
(Expiration: Sep, 2028)
DSM NUTRITIONAL PRODUCTS
EP2477638B1 Probiotic Stabilization MJN US HOLDINGS LLC Oct, 2020
(Expiration: Sep, 2030)
CHR HANSEN NATURAL COLORS
NUTRICIA
EP2762140B1 Treatment Of Solid Brain Tumours With A Rapamycin Derivative NOVARTIS AG Oct, 2020
(Expiration: Feb, 2022)
ETHYPHARM
GENERICS UK
EP2359800B1 Composition For Cosmetic Treatment Of Keratin Fibres Comprising Volatile Linear Alkanes, C8-30 Fatty Alcohols And Mono- Or Polyglycosides LOREAL SA Oct, 2020
(Expiration: Dec, 2030)
HENKEL
EP3092226B1 Indazole Compounds As Irak4 Inhibitors AURIGENE DISCOVERY TECHNOLOGIES LTD Oct, 2020
(Expiration: Jan, 2035)
BAYER BAYER PHARMA
EP2776066B1 Use Of Rank/Rankl Antagonists For Treating Neuromuscular Disorders, Genetic Myopathies And/Or Non Genetic Myopathies And/Or For Regulating Skeletal And Cardiac Muscle Disuse, Diseases And Aging UNIVERSITE LAVAL Oct, 2020
(Expiration: Nov, 2032)
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
EP1617820B1 Dry Power Inhaler Devices And Dry Power Formulations For Enhancing Dosing Efficiency VECTURA LTD Oct, 2020
(Expiration: Apr, 2024)
TEVA UK
EP2766014B1 Methods Of Treating Pediatric Patients Using Dexmedetomidine HOSPIRA INC Sep, 2020
(Expiration: Sep, 2032)
FRESENIUS KABI DEUTSCHLAND
EP2164496B1 Formulations Containing Triazinones And Iron BAYER INTELLECTUAL PROPERTY GMBH Sep, 2020
(Expiration: May, 2028)
CEVA SANTE ANIMALE
EP2753191B1 Use Of Infant Formula With Large Lipid Globules NUTRICIA NV Sep, 2020
(Expiration: Sep, 2032)
NESTEC
EP2949335B1 Low Frequency Glatiramer Acetate Therapy YEDA RESEARCH AND DEVELOPMENT CO LTD Sep, 2020
(Expiration: Aug, 2030)
ALVOGEN IPCO
GENERICS UK TRADING MYLAN
G L PHARMA
HEXAL
MYLAN TEORANTA TRADING MYLAN INSTITUTIONAL
SYNTHON BVGENTHON
EP2968302B9 Combination Of Direct Acting Antiviral Agents And Ribavirin For Treating Hcv Patients ABBVIE INC Sep, 2020
(Expiration: Mar, 2034)
GENERICS UK
EP2073828B1 Composition To Treat Or Prevent Gastrointestinal Infection NUTRICIA NV Aug, 2020
(Expiration: Sep, 2027)
FRESENIUS KABI DEUTSCHLAND
EP2797576B1 Hair Dyeing Composition KAO GERMANY GMBH Aug, 2020
(Expiration: Dec, 2032)
HENKEL
EP2678011B1 Antitumoral Combination Comprising Cabazitaxel And Cisplatin AVENTIS PHARMA SA Aug, 2020
(Expiration: Feb, 2032)
GENERICS UK
EP3116534B1 Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders BAXALTA GMBH Aug, 2020
(Expiration: Mar, 2035)
OCTAPHARMA
EP1579847B1 Cosmetic And Dermatological Solar Compositions BEIERSDORF AG Jul, 2020
(Expiration: Mar, 2025)
BASF
DALLI WERKE
EMIL KIESSLING
MERCK PATENT
STADA ARZNEIMITTEL
EP2624859B1 Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders MEDIMMUNE LTD Jul, 2020
(Expiration: Sep, 2031)
STRAWMAN
EP2922532B1 5-Aminosalicylic Acid Capsule Formulation ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD Jul, 2020
(Expiration: Nov, 2033)
WIBBELMANN
EP3186281B1 Combination Therapy With A Hyaluronan-Degrading Enzyme And An Immune Checkpoint Inhibitor HALOZYME INC Jul, 2020
(Expiration: Aug, 2035)
J A KEMP
EP2509565B1 Emulsifier-Free, Polymer-Stabilized Foam Formulations NEUBOURG SKIN CARE GMBH AND CO KG Jul, 2020
(Expiration: Dec, 2030)
HENKEL
EP1477189B1 Process For Production Of Pressure-Sensitive Adhesive Moldings Comprising Crosslinked Polymers As The Main Component HISAMITSU PHARMACEUTICAL CO INC Jun, 2020
(Expiration: Jan, 2023)
LTS LOHMANN THERAPIE SYSTEME
EP3250185B1 Ophthalmic Suspension Composition BAUSCH AND LOMB INC Jun, 2020
(Expiration: Jan, 2036)
ALLERGAN
BREUER
EUROPEAN OPPOSITIONS
EP3038647B1 Combination Therapy For The Treatment Of Glioblastoma F HOFFMANN LA ROCHE AG Jun, 2020
(Expiration: Aug, 2034)
AMGEN
NEUEFEIND
EP2818156B1 Perfumed Cosmetic Preparation BEIERSDORF AG Jun, 2020
(Expiration: Mar, 2029)
BASF
DALLI WERKE
EP2954892B1 Solid Compositions ABBVIE IRELAND ULC Jun, 2020
(Expiration: Jun, 2031)
AECHTER
EP1714960B1 Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als MITSUBISHI TANABE PHARMA CORP May, 2020
(Expiration: Feb, 2025)
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
EP1768646B1 Cosmetic Sprays UNILEVER PLC May, 2020
(Expiration: May, 2025)
HENKEL
EP3086761B1 Aqueous Cosmetic Composition Comprising Alkylcellulose, Non-Volatile Oils, A Hydrophilic Gelling Polymer And A Polyol LOREAL SA Apr, 2020
(Expiration: Dec, 2034)
HENKEL
EP2944323B1 Agents For Treating Tumours, Use And Method Thereof DINGFU BIOTARGET CO LTD Apr, 2020
(Expiration: Jan, 2033)
GLAXOSMITHKLINE
MERCK PATENT
PFIZER
EP1633766B1 Modified Fluorinated Nucleoside Analogues GILEAD PHARMASSET LLC Apr, 2020
(Expiration: Apr, 2024)
GILLARD
EP2258346B1 Solid Pharmaceutical Dosage Form Comprising An Hiv Protease Inhibitor Solid Dispersion ABBVIE INC Apr, 2020
(Expiration: Aug, 2024)
F HOFFMANN LA ROCHE
EP2213284B1 Preparation For Application To Body Surface And Preparation Holding Sheet For Application To Body Surface BIOSERENTACH CO LTD Apr, 2020
(Expiration: Nov, 2028)
LEO PHARMA
LTS LOHMANN THERAPIE SYSTEM
EP2988722B1 Composition Comprising Henna And/Or Indigo, An Oil And A Saccharide, And Hair Dyeing Process Using The Same LOREAL SA Apr, 2020
(Expiration: Apr, 2034)
COTY
EP2582697B1 Nanostructured Aprepitant Compositions, Process For The Preparation Thereof And Pharmaceutical Compositions Containing Them NANOFORM CARDIOVASCULAR THERAPEUTICS LTD Mar, 2020
(Expiration: Jun, 2031)
ALKERMES PHARMA IRELAND
EP3045176B8 Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione CELGENE CORP Mar, 2020
(Expiration: Sep, 2024)
GENERICS UK
EP3045175B8 Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione CELGENE CORP Mar, 2020
(Expiration: Sep, 2024)
GENERICS UK
EP1962778B1 Improved Oral Compositions Comprising Zinc Citrate And/Or Tocopherol Agents COLGATE PALMOLIVE CO Mar, 2020
(Expiration: Dec, 2026)
UNILEVER UNILEVER
EP2598121B1 A Method Of Controlling The Release Of An Active Ingredient From A Dosage Form DOW GLOBAL TECHNOLOGIES LLC Mar, 2020
(Expiration: Jun, 2031)
TYLOSE & COKG
EP3042659B8 Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione CELGENE CORP Mar, 2020
(Expiration: Sep, 2024)
BACHELIN
GENERICS UK
HAMM&WITTKOPP PATENTANWLTE PARTMBB
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
PRU
EP3025705B8 Stable Ivabradine Formulations SANOFI ILAC SANAYI VE TICARET AS Mar, 2020
(Expiration: Nov, 2034)
HGF
EP3119436B1 Sheet-Like Structure For The Controlled Release Of Active Substances CARL FREUDENBERG KG Mar, 2020
(Expiration: Mar, 2035)
MAHLE
EP3204045B1 Pharmaceutical Formulations For The Oral Delivery Of Peptide Or Protein Drugs CYPRUMED GMBH Mar, 2020
(Expiration: Oct, 2035)
SANOFI
EP2731613B1 Treatment Of Excessive Menstrual Bleeding Associated With Uterine Fibroids PREGLEM SA Mar, 2020
(Expiration: Jul, 2032)
ACCORD HEALTHCARE
GENERICS UK
HELM
HEXAL
ZENTIVA KS
EP2403520B1 Insulin Formulations For Rapid Uptake ELI LILLY AND CO Mar, 2020
(Expiration: Mar, 2030)
BOHMANN
MAIKOWSKI & NINNEMANN PATENTANWLTE PARTNERSCHAFT MBB
EP2582683B1 Treatment Of Gout And Hyperuricemia ARDEA BIOCIENCES INC Mar, 2020
(Expiration: Jun, 2031)
ALFRED E TIEFENBACHER
BLLE DR
HEXAL
EP2547216B1 Infant Nutrition For Improving Fatty Acid Composition Of Brain Membranes NUTRICIA NV Feb, 2020
(Expiration: Mar, 2031)
ABBOTT LABORATORIES
EP2535355B1 Antibodies Against Cd38 For Treatment Of Multiple Myeloma GENMAB AS Feb, 2020
(Expiration: Mar, 2026)
SECERNA
EP3076930B1 Agent For Oxidatively Dyeing Hair Containing Specific Combinations Of Developers And Couplers HENKEL AG AND CO KGAA Feb, 2020
(Expiration: Nov, 2034)
LOREAL
EP2421841B1 Improved Method Of Achieving And Maintaining A Specified Alkylene Oxide Production Parameter With A High Efficiency Catalyst DOW TECHNOLOGY INVESTMENTS LLC Feb, 2020
(Expiration: Apr, 2030)
BASF
EP2550972B1 Klotho-Beta For Use In Treating Cancer, Liver Disorders, Gallstones, Wasting Syndrome And Obesity-Related Diseases GENENTECH INC Feb, 2020
(Expiration: Apr, 2028)
MATHYS & SQUIRE
NGM BIOPHARMACEUTICALS
EP2477617B1 Free-Standing Biodegradable Patch BIOINSPIRE TECHNOLOGIES INC Feb, 2020
(Expiration: Sep, 2030)
ETHICON
EP2368914B1 Anti-5T4 Antibodies And Uses Thereof WYETH LLC Feb, 2020
(Expiration: Mar, 2027)
SYNTHON BIOPHARMACEUTICALS
EP2393477B1 Use Of A Glucocorticoid Composition For The Treatment Of Severe And Uncontrolled Asthma VECTURA GMBH Feb, 2020
(Expiration: Feb, 2030)
TEVA UK
EP2751267B1 Methods For The Treatment Of Breast Cancer SYNDAX PHARMACEUTICALS INC Feb, 2020
(Expiration: Aug, 2032)
GENERICS UK
HEXAL
EP1731152B1 Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine EURO CELTIQUE SA Feb, 2020
(Expiration: Feb, 2018)
GALLAFENT
HEXAL
TESA LABTEC
EP2665461B1 Hair Coloring Compositions With A Non-Ammonia Alkalizing Agent NOXELL CORP Feb, 2020
(Expiration: Jan, 2032)
HENKEL
KAO GERMANY
EP3008064B1 Stable Pemetrexed Arginine Salt And Compositions Comprising It SYNTHON BV Feb, 2020
(Expiration: Jun, 2033)
LARSEN & BIRKEHOLM
EP2611429B1 Mesalazine Tablet Having Improved Dissolution DISPHAR INTERNATIONAL BV Feb, 2020
(Expiration: Sep, 2031)
TILLOTTS PHARMA
EP2211896B1 Compositions For The Treatment Of Gastrointestinal Inflammation MERITAGE PHARMA INC Jan, 2020
(Expiration: Nov, 2028)
DR FALK PHARMA
PRFER & PARTNER MBB
EP2598119B1 Preservative Free Brimonidine And Timolol Solutions ALLERGAN INC Jan, 2020
(Expiration: Jul, 2031)
INSTONE
WCHTERSHUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB
EP2694095B1 Compositions Comprising Glucagon Analogs And Methods Of Making And Using The Same LONGEVITY BIOTECH INC Jan, 2020
(Expiration: Apr, 2032)
ZEALAND PHARMA
EP2789627B1 Porcine Circovirus Type-2 Subunit Vaccine SBC VIRBAC LTD Jan, 2020
(Expiration: Dec, 2032)
MERIAL
EP3196301B1 Methods And Compositions For The Treatment Of Monogenic Diseases SANGAMO THERAPEUTICS INC Jan, 2020
(Expiration: Mar, 2033)
LEEMING
MATHYS & SQUIRE
PATENT BOUTIQUE
EP2425824B1 Pharmaceutical Preparation Containing Oxycodone And Naloxone EURO CELTIQUE SA Jan, 2020
(Expiration: Apr, 2023)
ACINO PHARMA
DEVELCO PHARMA SCHWEIZ
ETHYPHARM
GLENMARK PHARMACEUTICALS EUROPE
G L PHARMA
HEXAL SANDOZ
INTAS PHARMACEUTICALS
KRKA
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA
EP2961399B1 Administration Of Gamma Hydroxybutyrate With Monocarboxylate Transporters JAZZ PHARMACEUTICALS IRELAND LTD Jan, 2020
(Expiration: Feb, 2034)
HEXAL
HOFFMANN EITLE
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
EP2729165B1 Immunogenic Combination Compositions And Uses Thereof GLAXOSMITHKLINE BIOLOGICALS SA Jan, 2020
(Expiration: Jul, 2032)
PFIZER
EP2512491B1 Hbv Antisense Inhibitors GLAXO GROUP LTD Jan, 2020
(Expiration: Oct, 2030)
ROCHE INNOVATION CENTER COPENHAGEN
EP2900252B1 Agent For Enhancing Immunity Containing Glutathione KYOWA HAKKO BIO CO LTD Jan, 2020
(Expiration: Sep, 2033)
HGF
EP2976059B1 Agent For The Temporary Shaping Of Keratin-Containing Fibres HENKEL AG AND CO KGAA Jan, 2020
(Expiration: Feb, 2034)
LOREAL
EP2547217B1 Infant Nutrition For Improving Fatty Acid Composition Of Brain Membranes NUTRICIA NV Jan, 2020
(Expiration: Mar, 2031)
NESTEC